Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

about

Lyme arthritis: current concepts and a change in paradigm.

P2860

Q37001131-A70DA5A6-52EA-4336-BE23-33B24374AB1C

P2860

Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

Item

http://www.wikidata.org/entity/Q35783591

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@ast

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@en

type

Item

label

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@ast

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@en

prefLabel

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@ast

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@en

P1476

Anti-p19 antibody treatment ex ...... hances borreliacidal activity.

@en

P2093

Dean T Nardelli

http://www.w3.org/2001/XMLSchema#string

Jose R Torrealba

http://www.w3.org/2001/XMLSchema#string

Ronald F Schell

http://www.w3.org/2001/XMLSchema#string

Sara Heil Peterson

http://www.w3.org/2001/XMLSchema#string

Steven M Callister

http://www.w3.org/2001/XMLSchema#string

Thomas F Warner

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis of lyme borreliosis.

Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells

Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

The expression pattern of the cell cycle inhibitor p19(INK4d) by progenitor cells of the rat embryonic telencephalon and neonatal anterior subventricular zone

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

Cellular and acellular pertussis vaccines in adults.

Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

P304

510-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00005-07

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17360856

http://www.w3.org/2001/XMLSchema#string

P921

Lyme disease

P932

1865634

http://www.w3.org/2001/XMLSchema#string

Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

about

P2860

P2860

Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932